Standardization of High Sensitivity Minimal Residual Disease Monitoring in Multiple Myeloma: An Experience in Tertiary Cancer Centre

2019 ◽  
Vol 19 (10) ◽  
pp. e357
Author(s):  
P.G. Subramanian ◽  
Gaurav Chatterjee ◽  
Sitaram Ghogale ◽  
Anant Gokarn ◽  
Prathyusha Gudapati ◽  
...  
HemaSphere ◽  
2019 ◽  
Vol 3 (S1) ◽  
pp. 268
Author(s):  
J. Martinez-Lopez ◽  
S. Wong ◽  
N. Shah ◽  
N. Bahri ◽  
T. Martin ◽  
...  

Blood ◽  
2016 ◽  
Vol 127 (25) ◽  
pp. 3165-3174 ◽  
Author(s):  
Bruno Paiva ◽  
Maria-Teresa Cedena ◽  
Noemi Puig ◽  
Paula Arana ◽  
Maria-Belen Vidriales ◽  
...  

Key Points MRD monitoring is one of the most relevant prognostic factors in elderly MM patients, irrespective of age or cytogenetic risk. Second-generation MFC immune profiling concomitant to MRD monitoring also helped to identify patients with different outcomes.


2002 ◽  
Vol 15 (1) ◽  
pp. 197-222 ◽  
Author(s):  
Faith E. Davies ◽  
Andrew C. Rawstron ◽  
Roger G. Owen ◽  
Gareth J. Morgan

Sign in / Sign up

Export Citation Format

Share Document